- Home
- NXTC vs GDC Comparison
NXTC vs GDC Comparison
Compare NXTC & GDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- GDC
- Stock Information
- Founded
- NXTC 2015
- GDC 2015
- Country
- NXTC United States
- GDC United States
- Employees
- NXTC N/A
- GDC N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- GDC Steel/Iron Ore
- Sector
- NXTC Health Care
- GDC Industrials
- Exchange
- NXTC Nasdaq
- GDC Nasdaq
- Market Cap
- NXTC 40.3M
- GDC 34.8M
- IPO Year
- NXTC 2019
- GDC N/A
- Fundamental
- Price
- NXTC $1.31
- GDC $2.80
- Analyst Decision
- NXTC Strong Buy
- GDC
- Analyst Count
- NXTC 2
- GDC 0
- Target Price
- NXTC $4.00
- GDC N/A
- AVG Volume (30 Days)
- NXTC 44.0K
- GDC 717.4K
- Earning Date
- NXTC 11-07-2024
- GDC 11-22-2024
- Dividend Yield
- NXTC N/A
- GDC N/A
- EPS Growth
- NXTC N/A
- GDC N/A
- EPS
- NXTC N/A
- GDC N/A
- Revenue
- NXTC N/A
- GDC N/A
- Revenue This Year
- NXTC N/A
- GDC N/A
- Revenue Next Year
- NXTC N/A
- GDC N/A
- P/E Ratio
- NXTC N/A
- GDC N/A
- Revenue Growth
- NXTC N/A
- GDC N/A
- 52 Week Low
- NXTC $1.03
- GDC $0.59
- 52 Week High
- NXTC $2.57
- GDC $12.18
- Technical
- Relative Strength Index (RSI)
- NXTC 45.61
- GDC 58.30
- Support Level
- NXTC $1.30
- GDC $1.29
- Resistance Level
- NXTC $1.60
- GDC $3.37
- Average True Range (ATR)
- NXTC 0.08
- GDC 0.36
- MACD
- NXTC 0.00
- GDC 0.24
- Stochastic Oscillator
- NXTC 12.12
- GDC 72.74
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About GDC GD Culture Group Limited
GD Culture Group Ltd focuses its business on three segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce and 3) Live streaming interactive game. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.